NRNP6635 MIDTERM SOLUTIONS PRACTICE
SET 2026 VIEW AHEAD TESTED QUESTIONS
◉ Panic tx. Answer: -Exposure therapy
-Cognitive behavioral therapy
-Medications
• SSRIs
• Benzodiazepines in emergencies
-Combination of modalities
◉ Tx plan to support dx of Adjustment Disorder with Anxiety.
Answer: -Psychosocial support
• Provide reassurance and emotional support to the patient.
-Lifestyle modification: Mindfulness
• Mindfulness or relaxation training can assist clients with
controlling excessive feelings of worry or anxiety.
-Lifestyle modification: Limit alcohol
• Alcohol can increase anxiety levels
-Lifestyle modification: Sleep hygiene
,• Regular, consistent sleep patterns of 7-8 hours per night can
reduce feelings of anxiety.
-Pharmacologic therapy: Sertraline
• An SSRI, such as sertraline, may be indicated to help Phoebe cope
with her feelings of anxiety.
◉ Patients with a hx of childhood trauma: cuts response and
remission rate of SSRIs __________. Answer: in half
◉ CUS. Answer: chronic unpredictable stress
◉ anhedonia. Answer: inability to experience pleasure
◉ rumination. Answer: compulsive fretting; overthinking about our
problems and their causes
-responds to atypical antipsychotics
◉ Neurotransmitters involved in anxiety:. Answer: Norepinephrine-
excitatory
Serotonin- quick turnover
GABA-inhibitory
Other Brain Chemicals
,HPA axis-cortisol
Corticotrophin Releasing Hormone- CRH
Brain-Derived Neurotrophic Factor-BDNF
◉ Differential Diagnoses for anxiety:. Answer: Obsessive-compulsive
disorder.
Panic disorder
Major depressive disorder
Social phobia
Phobias
Adjustment disorder with anxiety
Social Anxiety Disorder
Substance-related disorders
Medical Disorders
◉ DSM-5 criteria for GAD. Answer: excessive anxiety and worry
occurring more days than not for at least six months. The person
finds it difficult to control and experiences at least three symptoms:
restlessness, fatigue, difficulty concentrating, irritability, muscle
tension, and sleep disturbance
◉ First-line psychotropic medications used to treat anxiety
disorders are:. Answer: selective serotonin reuptake inhibitors
, (SSRIs) that act on the serotonin system and indirectly on the GABA
system
-There are also non-benzodiazepine anxiolytics that may help
manage anxiety symptoms, including buspirone, gabapentin, and
propranolol
-Also, Clonidine or Guanfacine may be used with children
-Treatment is usually continued for 6 to 12 months
-SNRI's and SSRI's have become the first-line pharmacological
intervention
◉ separation anxiety disorder. Answer: fearful or anxious about
separation from attachment figures to a degree that is
developmentally inappropriate
-persistent fear or anxiety about harm coming to attachment figures
and events that could lead to loss of or separation
-reluctance to go away
-nightmares and physical symptoms of distress
◉ Selective mutism. Answer: characterized by a consistent failure to
speak in social situations in
which there is an expectation to speak (e.g., school) even though the
individual speaks in other situations.
-significant consequences on achievement in aca-demic or
occupational settings
SET 2026 VIEW AHEAD TESTED QUESTIONS
◉ Panic tx. Answer: -Exposure therapy
-Cognitive behavioral therapy
-Medications
• SSRIs
• Benzodiazepines in emergencies
-Combination of modalities
◉ Tx plan to support dx of Adjustment Disorder with Anxiety.
Answer: -Psychosocial support
• Provide reassurance and emotional support to the patient.
-Lifestyle modification: Mindfulness
• Mindfulness or relaxation training can assist clients with
controlling excessive feelings of worry or anxiety.
-Lifestyle modification: Limit alcohol
• Alcohol can increase anxiety levels
-Lifestyle modification: Sleep hygiene
,• Regular, consistent sleep patterns of 7-8 hours per night can
reduce feelings of anxiety.
-Pharmacologic therapy: Sertraline
• An SSRI, such as sertraline, may be indicated to help Phoebe cope
with her feelings of anxiety.
◉ Patients with a hx of childhood trauma: cuts response and
remission rate of SSRIs __________. Answer: in half
◉ CUS. Answer: chronic unpredictable stress
◉ anhedonia. Answer: inability to experience pleasure
◉ rumination. Answer: compulsive fretting; overthinking about our
problems and their causes
-responds to atypical antipsychotics
◉ Neurotransmitters involved in anxiety:. Answer: Norepinephrine-
excitatory
Serotonin- quick turnover
GABA-inhibitory
Other Brain Chemicals
,HPA axis-cortisol
Corticotrophin Releasing Hormone- CRH
Brain-Derived Neurotrophic Factor-BDNF
◉ Differential Diagnoses for anxiety:. Answer: Obsessive-compulsive
disorder.
Panic disorder
Major depressive disorder
Social phobia
Phobias
Adjustment disorder with anxiety
Social Anxiety Disorder
Substance-related disorders
Medical Disorders
◉ DSM-5 criteria for GAD. Answer: excessive anxiety and worry
occurring more days than not for at least six months. The person
finds it difficult to control and experiences at least three symptoms:
restlessness, fatigue, difficulty concentrating, irritability, muscle
tension, and sleep disturbance
◉ First-line psychotropic medications used to treat anxiety
disorders are:. Answer: selective serotonin reuptake inhibitors
, (SSRIs) that act on the serotonin system and indirectly on the GABA
system
-There are also non-benzodiazepine anxiolytics that may help
manage anxiety symptoms, including buspirone, gabapentin, and
propranolol
-Also, Clonidine or Guanfacine may be used with children
-Treatment is usually continued for 6 to 12 months
-SNRI's and SSRI's have become the first-line pharmacological
intervention
◉ separation anxiety disorder. Answer: fearful or anxious about
separation from attachment figures to a degree that is
developmentally inappropriate
-persistent fear or anxiety about harm coming to attachment figures
and events that could lead to loss of or separation
-reluctance to go away
-nightmares and physical symptoms of distress
◉ Selective mutism. Answer: characterized by a consistent failure to
speak in social situations in
which there is an expectation to speak (e.g., school) even though the
individual speaks in other situations.
-significant consequences on achievement in aca-demic or
occupational settings
